Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.

Okai Annette F; Howard Annette M; Williams Mitzi J; Justine Brink; Chiayi Chen; tamela stuchiner; Elizabeth Baraban; Grace Jeong; Stanley Cohan

Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.

Okai Annette F, Howard Annette M, Williams Mitzi J, Justine Brink, Chiayi Chen, tamela stuchiner, Elizabeth Baraban, Grace Jeong, Stanley Cohan

Research output: Contribution to journal › Article

Abstract

Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical presentation, increased disease incidence and burden, and worsened long-term outcomes versus their White counterparts. Due to limited data available for African Americans in MS clinical trials, it is difficult to make informed, generalizable conclusions about the natural history, prognosis, and therapeutic response in this population. In this narrative review, we highlight the nature and magnitude of the health disparities experienced by African Americans with MS and underscore the pressing need to increase knowledge about and understanding of MS disease manifestations in this group. Additionally, we describe the mission and objectives of the recently established National African Americans with Multiple Sclerosis Registry (NAAMSR), which is intended to be a platform to advance the care of African Americans with MS and address health disparities they may experience.

Original language	Undefined/Unknown
Journal	Articles, Abstracts, and Reports
State	Published - Apr 25 2022

Access to Document

http://digitalcommons.psjhealth.org/publications/6020

Cite this

@article{041efa599e7449898fd665f29160b96f,

title = "Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.",

abstract = "Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical presentation, increased disease incidence and burden, and worsened long-term outcomes versus their White counterparts. Due to limited data available for African Americans in MS clinical trials, it is difficult to make informed, generalizable conclusions about the natural history, prognosis, and therapeutic response in this population. In this narrative review, we highlight the nature and magnitude of the health disparities experienced by African Americans with MS and underscore the pressing need to increase knowledge about and understanding of MS disease manifestations in this group. Additionally, we describe the mission and objectives of the recently established National African Americans with Multiple Sclerosis Registry (NAAMSR), which is intended to be a platform to advance the care of African Americans with MS and address health disparities they may experience.",

author = "{Annette F}, Okai and {Annette M}, Howard and {Mitzi J}, Williams and Justine Brink and Chiayi Chen and tamela stuchiner and Elizabeth Baraban and Grace Jeong and Stanley Cohan",

year = "2022",

month = apr,

day = "25",

language = "Undefined/Unknown",

journal = "Articles, Abstracts, and Reports",

}

TY - JOUR

T1 - Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.

AU - Annette F, Okai

AU - Annette M, Howard

AU - Mitzi J, Williams

AU - Brink, Justine

AU - Chen, Chiayi

AU - stuchiner, tamela

AU - Baraban, Elizabeth

AU - Jeong, Grace

AU - Cohan, Stanley

PY - 2022/4/25

Y1 - 2022/4/25

N2 - Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical presentation, increased disease incidence and burden, and worsened long-term outcomes versus their White counterparts. Due to limited data available for African Americans in MS clinical trials, it is difficult to make informed, generalizable conclusions about the natural history, prognosis, and therapeutic response in this population. In this narrative review, we highlight the nature and magnitude of the health disparities experienced by African Americans with MS and underscore the pressing need to increase knowledge about and understanding of MS disease manifestations in this group. Additionally, we describe the mission and objectives of the recently established National African Americans with Multiple Sclerosis Registry (NAAMSR), which is intended to be a platform to advance the care of African Americans with MS and address health disparities they may experience.

AB - Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical presentation, increased disease incidence and burden, and worsened long-term outcomes versus their White counterparts. Due to limited data available for African Americans in MS clinical trials, it is difficult to make informed, generalizable conclusions about the natural history, prognosis, and therapeutic response in this population. In this narrative review, we highlight the nature and magnitude of the health disparities experienced by African Americans with MS and underscore the pressing need to increase knowledge about and understanding of MS disease manifestations in this group. Additionally, we describe the mission and objectives of the recently established National African Americans with Multiple Sclerosis Registry (NAAMSR), which is intended to be a platform to advance the care of African Americans with MS and address health disparities they may experience.

M3 - Article

JO - Articles, Abstracts, and Reports

JF - Articles, Abstracts, and Reports

ER -